Efficacy of Er:YAG Laser in Decontamination of Dental Implants: An In-Vitro Study
NCT ID: NCT03100435
Last Updated: 2023-03-31
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
8 participants
INTERVENTIONAL
2017-04-20
2018-10-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
After the implant is placed, natural bacteria from the mouth can develop around implants just like around natural teeth. Studies have shown that bacterial contamination can cause peri-implantitis- gum disease or inflammation around the implant, eventually leading to bone loss. Removing bacteria from dental implant surfaces can prevent peri-implantitis, and surface debridement constitutes the basis of treatment of peri-implant disease.
Typically, mechanical hand instrumentation using curettes to remove biofilm and calculus is the main basis for periodontal therapy. However, total debridement is difficult, and the hand tools may damage the surface of the implant and making it more plaque retentive. Studies have shown that mechanical non-surgical therapy alone is not sufficient to treat peri-implantitis.
There is evidence that a dental laser may be an effective method to remove bacteria from implant surfaces, with less damage to the surface. One type of dental laser, Er:YAG, appears optimal for implant decontamination as the Er:YAG laser energy is primarily absorbed by water, resulting in vaporization of bacteria and minimal surface alterations on the implant surface.The aim of this study is to evaluate the efficiency of biofilm decontamination of Er:YAG laser compared to carbon fiber curette.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surface Decontamination in Treatment of Peri-Implantitis
NCT03114956
Efficacy of Non-surgical and Surgical Surface Decontamination Methods on Peri-implantitis-affected Implants
NCT06430268
Efficacy of an Oral Hygiene Implant Protocol
NCT04462341
Evaluation of Fractalkine and Its Receptor in Peri-implantitis
NCT06685523
Laser Therapy Treatment of Peri-implantitis.
NCT01972399
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the first phase of the study, custom mouth guards that holds multiple titanium discs will be fabricated. Experimental subjects will be instructed to wear this mouth guard for 72 hours, during which time a natural bacterial biofilm will form on the disc surfaces.
The second phase of the study will be performed ex vivo after collecting the discs from the subjects. Discs retrieved from each mouth guard will be randomized over the 4 treatment groups, so that each subject will contribute two discs to each treatment group: 1) Er:YAG laser, 2) carbon fiber curette, 3) combination of carbon fiber curette and Er:YAG laser, and 4) no treatment (control). The biofilm will be stained and the residual biofilm will be visualized under fluorescence microscopy. Statistical methods will be used to determine the significance of each treatment modality.
The primary outcome of the study is the percent area of the titanium disc covered by biofilm.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Er:YAG Laser
Er:YAG Laser only
Er:YAG Laser
Titanium disks will be decontaminated ex-vivo with the Er:YAG laser.
Carbon Fiber Curette
Carbon fiber curette only
Carbon Fiber Curette
Titanium disks will be decontaminated ex-vivo with carbon fiber curettes
Er:YAG Laser + Carbon Fiber Curette
Combination of Er:YAG Laser and carbon fiber curette
Er:YAG Laser
Titanium disks will be decontaminated ex-vivo with the Er:YAG laser.
Carbon Fiber Curette
Titanium disks will be decontaminated ex-vivo with carbon fiber curettes
No Treatment
No treatment (control)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Er:YAG Laser
Titanium disks will be decontaminated ex-vivo with the Er:YAG laser.
Carbon Fiber Curette
Titanium disks will be decontaminated ex-vivo with carbon fiber curettes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects diagnosed with clinical health, gingivitis, or slight chronic periodontitis defined as periodontal inflammation with slight (1-2mm) attachment loss.
Exclusion Criteria
* Subjects diagnosed with moderate or severe chronic periodontitis.
* Subjects with known allergy to acrylic or titanium.
* Subjects who smoke cigarettes, cigars, snuff tobacco, or any other form of smoking.
* Subjects with a history of antibiotic treatment within the last six months.
* Subjects with contraindications to wearing a mouth guard, such as chronic obstructive pulmonary disease or severe sleep apnea.
* Subjects with uncontrolled or debilitating medical conditions, including but not limited to subjects with uncontrolled diabetes, hematologic disorders, cancers, immunosuppression, severe cardiovascular disease, or uncontrolled thyroid disease
* Subjects that are currently pregnant according to self-report
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tufts University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robert Gyurko, DMD, PhD
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Gyurko, DMD, PhD
Role: PRINCIPAL_INVESTIGATOR
TUSDM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tufts University School of Dental Medicine
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12380
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.